Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain

• Status: Completed
• Trial end date: 2019-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Endoscopic sinus surgery (ESS) is a prevalent surgical procedure. It is required in many chronic rhinosinusitis for whom the medical treatment failed. In order to improve the postoperative management of patients treated with ESS, we aim to assess the analgesic action of local injection of ropivacaine in the nasal fossa.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Lille
• Treatments: Pharmaceutical Solutions; Ropivacaine

Criteria

Inclusion Criteria:

• patients requiring endoscopic sinus surgery

• ASA score 1 or 2

• patients with health care insurance

• approved consent

Exclusion Criteria:

• any sinonasal malignant tumor

• renal failure, hepatic disorder, respiratory deficiency, cardiovascular diseases

• neurologic disorders

• alcohol or drugs addiction

• preoperative facial pain from an extranasal origin

• coagulation disorders

• antidepressive treatment